Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Randomised controlled trials of preventive therapy for MDRTB household contacts (HIV-infected or HIV-uninfected) expected to commence recruitment in 2015

From: What can we offer to 3 million MDRTB household contacts in 2016?

Name of trial Location Population Intervention and comparator Months of treatment/follow-up Clinical trials registry #
TB CHAMP South Africa Children <5 years Levofloxacin vs. placebo 6/18 -
PHOENix ACTG sites All contacts (Adults and children) Delamanid vs. isoniazid 6/22 -
V-QUIN Vietnam All contacts (Adults and children) Levofloxacin vs. placebo 6/30 ACTRN12616000215426